Angioedema Explained: Symptoms, Causes, And Treatment

Angioedema involves sudden, often painful swelling in deeper skin layers and mucous membranes, distinguishing it from superficial hives. This condition affects areas like the face, lips, tongue, throat, genitals, and extremities, sometimes leading to life-threatening airway obstruction.

Recognizing the Signs of Angioedema

The primary symptom is non-pitting edema, meaning the skin does not blanch under pressure, creating firm, asymmetrical swellings. Unlike hives, which itch due to superficial involvement, angioedema often causes discomfort or burning pain because it penetrates deeper tissues.

• Facial swelling: Eyelids, cheeks, and lips commonly affected, potentially impairing vision or speech.
• Oral and throat involvement: Tongue or laryngeal edema can cause hoarseness, drooling, or breathing difficulty.
• Abdominal crises: In hereditary forms, gut wall swelling mimics surgical emergencies with nausea, vomiting, and severe pain.
• Extremities and genitals: Hands, feet, or genital areas swell, limiting movement.

Episodes vary: acute cases resolve in hours to days, while chronic recurrent ones persist over weeks or recur unpredictably.

Core Mechanisms Behind Swelling

Angioedema arises from fluid leakage from blood vessels into tissues, driven by two main pathways: histamine-mediated and bradykinin-mediated.

Histamine pathway: Allergic triggers bind IgE on mast cells, prompting degranulation and histamine release. This dilates vessels and increases permeability, often with accompanying urticaria.

Bradykinin pathway: Independent of allergies, excess bradykinin—a vasodilator peptide—accumulates due to enzyme deficiencies or inhibitions, causing profound, prolonged swelling without hives.

Allergic and Idiopathic Forms

Most common, these stem from immune responses to foods (nuts, shellfish), drugs (penicillin), insect stings, or idiopathic mast cell activation. Infections or autoimmune flares also provoke histamine release.

Idiopathic angioedema lacks triggers, recurring chronically in 50% of urticaria patients. Vibrations or pressure may exacerbate.

Hereditary Angioedema: A Genetic Challenge

Hereditary angioedema (HAE) is rare, autosomal dominant, due to SERPING1 gene mutations affecting C1 esterase inhibitor (C1-INH)—a regulator of complement, contact, and fibrinolytic systems.

• HAE Type I (85%): Low C1-INH levels (<50% normal).
• HAE Type II (15%): Normal levels but dysfunctional protein.
• HAE with normal C1-INH: Emerging type III, often estrogen-linked, affecting women.

Attacks start before age 20, triggered by trauma, stress, or hormones, without hives. Family history aids suspicion, but de novo mutations occur.

Acquired and Drug-Induced Variants

Acquired angioedema (AAE) mimics HAE but arises later from autoantibodies against C1-INH or lymphoproliferative disorders. Low C1q distinguishes it.

Medications, especially ACE inhibitors (e.g., lisinopril), block bradykinin degradation, risking swelling in 0.1-0.7% of users, even years after starting.

Diagnostic Approaches

History and exam guide initial assessment: hives suggest allergy; isolated swelling points to bradykinin types.

Laboratory tests:

• C4 level: Low in HAE/AAE during/between attacks (repeat if normal handling doubted).
• C1-INH antigen/function: Low antigen in Type I/AAE; low function in Types I/II/AAE.
• C1q: Low in AAE only.

C3 is normal. For allergies, tryptase or IgE tests during acute phase.

Imaging or endoscopy rules out mimics in abdominal attacks.

Acute Management Strategies

Airway protection is priority: intubation if needed. For histamine-mediated:

• Epinephrine IM for anaphylaxis.
• Antihistamines (H1/H2 blockers), corticosteroids.

Bradykinin types resist these; fresh frozen plasma temporarily helps HAE.

Long-Term Control and Prophylaxis

Trigger avoidance: discontinue ACE inhibitors (use ARBs cautiously).

For HAE, targeted therapies approved post-2009 revolutionized care:

• On-demand: C1-INH concentrates (Berinert, Cinryze), kallikrein inhibitor (Ecallantide), bradykinin B2 antagonist (Icatibant).
• Prophylaxis: Lanadelumab (monoclonal anti-kallikrein), berotralstat (oral kallikrein inhibitor).

Attenuated androgens (danazol) for short-term prophylaxis, with monitoring for side effects.

Living with Recurrent Angioedema

Patients need action plans: self-injectable icatibant for HAE, medical alerts. Genetic counseling for hereditary cases. Quality of life improves with modern therapies, reducing hospitalizations.

Psychosocial support addresses anxiety from unpredictable attacks.

Emergency Warning Signs

• Stridor, dyspnea, or hypoxia: Call emergency services immediately.
• Sudden tongue/throat swelling.
• Abdominal pain with vomiting (rule out obstruction).

Frequently Asked Questions (FAQs)

What triggers an angioedema attack?

Common triggers include allergens, stress, trauma, infections, or medications like ACE inhibitors. Hereditary forms may lack obvious triggers.

Is angioedema contagious?

No, it results from internal mechanisms, not infection transmission.

How long does an episode last?

Histamine-mediated: 1-3 days; bradykinin: 2-5 days untreated.

Can angioedema be cured?

Allergic types managed by avoidance; HAE controlled but not cured with therapies.

Who is at risk for hereditary angioedema?

Those with family history or SERPING1 mutations; affects all ages, often starting in childhood.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb